Nanopublications

Matches in Nanopublications for { ?s ?p "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

Showing items 1 to 100 of ±264 with 100 items per page.

assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP127959.RAagu5oH80DrgoUGR-DI3XvKnbcHR2gxKyb8hjO-1JYec130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP127959.RAagu5oH80DrgoUGR-DI3XvKnbcHR2gxKyb8hjO-1JYec130_provenance.
NP128924.RARB3D_POz0DDWZ29dDafbKqKkQIuC432cDrlcPaHhBBs130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP128924.RARB3D_POz0DDWZ29dDafbKqKkQIuC432cDrlcPaHhBBs130_provenance.
NP129549.RAY6dhHgE5QlJbXJRQq85qT7vVv3fPv5Xw4lARlzizhrQ130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129549.RAY6dhHgE5QlJbXJRQq85qT7vVv3fPv5Xw4lARlzizhrQ130_provenance.
NP129550.RAY0KtLEcqWP4D8CQeEmlwA4iT-t0zV0SC0RHZgcd6PmM130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129550.RAY0KtLEcqWP4D8CQeEmlwA4iT-t0zV0SC0RHZgcd6PmM130_provenance.
NP136261.RAWppQKPttpk_8VADmwH60q71xNaIGEnAYueKD2QmlYpI130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP136261.RAWppQKPttpk_8VADmwH60q71xNaIGEnAYueKD2QmlYpI130_provenance.
NP138357.RAb9X7jZzEO6l1o_QFC-x-_OCQR_DC9qtIqOoIWo9F4Ho130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138357.RAb9X7jZzEO6l1o_QFC-x-_OCQR_DC9qtIqOoIWo9F4Ho130_provenance.
NP140976.RAR9rd8XrIjSnDrABgU8TBSITgSHvlPIEhnnbPsc24lYA130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140976.RAR9rd8XrIjSnDrABgU8TBSITgSHvlPIEhnnbPsc24lYA130_provenance.
NP143034.RAWHazru08bNr5lhNFNb5KFYLuYLxRqgwIUJ7TQZMOdVg130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143034.RAWHazru08bNr5lhNFNb5KFYLuYLxRqgwIUJ7TQZMOdVg130_provenance.
NP143844.RAQb66Q9fbgxVUJ7F2dp2Xw5N2xdUJa07KOHMkrTh_aNA130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143844.RAQb66Q9fbgxVUJ7F2dp2Xw5N2xdUJa07KOHMkrTh_aNA130_provenance.
NP143845.RAdA7J74mLjMV0T4rXLq6v60NuuORECEQhxRj1Wd-6AAQ130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143845.RAdA7J74mLjMV0T4rXLq6v60NuuORECEQhxRj1Wd-6AAQ130_provenance.
NP145077.RAXmhXt3F-umebRdVAig-i06yZhymOR8p0SBb_xtfENyk130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145077.RAXmhXt3F-umebRdVAig-i06yZhymOR8p0SBb_xtfENyk130_provenance.
NP145088.RAS7Or8VxVQzpcCElDK9Oo6s1k0Y-Erp_46ivJLirKMZ8130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145088.RAS7Or8VxVQzpcCElDK9Oo6s1k0Y-Erp_46ivJLirKMZ8130_provenance.
NP145936.RAX0JjwS_SwbRr5IBYEpX_5nWAcIz5Gd_-qRyPy2KOV6w130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145936.RAX0JjwS_SwbRr5IBYEpX_5nWAcIz5Gd_-qRyPy2KOV6w130_provenance.
NP147245.RAUM6DCuS8vYsJYcVh9uyCLW9ETeLtyi9zDCuE_WM-6mw130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147245.RAUM6DCuS8vYsJYcVh9uyCLW9ETeLtyi9zDCuE_WM-6mw130_provenance.
NP149210.RAfAbR47iFAuw-WkvEcPjT5NXmNfpguUA9UvoNG0nNKxI130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149210.RAfAbR47iFAuw-WkvEcPjT5NXmNfpguUA9UvoNG0nNKxI130_provenance.
NP149211.RAQzA3EOPY5jUZHkhRdk-radIsNOFMjC-K-4D2pIzLMJw130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149211.RAQzA3EOPY5jUZHkhRdk-radIsNOFMjC-K-4D2pIzLMJw130_provenance.
NP150487.RASWd1i0lm9PLc3GCKy90EjVVEEQqNJUej16JDDC1Mj6A130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP150487.RASWd1i0lm9PLc3GCKy90EjVVEEQqNJUej16JDDC1Mj6A130_provenance.
NP138346.RACD4GFr9IGf-QOk_ILBEinjy6Fv6DTYgCgHsJUQ5bJcw130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138346.RACD4GFr9IGf-QOk_ILBEinjy6Fv6DTYgCgHsJUQ5bJcw130_provenance.
NP150599.RABL1__KQP8u5R9dukgqO9F2hybdDdkAh6ifcNwC0GNew130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP150599.RABL1__KQP8u5R9dukgqO9F2hybdDdkAh6ifcNwC0GNew130_provenance.
NP116444.RAABxRY6_a_QtJ4SVGtgaS6tkgQtHZAQkkpUcmG4Np55U130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP116444.RAABxRY6_a_QtJ4SVGtgaS6tkgQtHZAQkkpUcmG4Np55U130_provenance.
NP127266.RA9oM4BbvVvvFABQ6HNs3rOJIJ5ihNdZYLjjE4MlFCUjM130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP127266.RA9oM4BbvVvvFABQ6HNs3rOJIJ5ihNdZYLjjE4MlFCUjM130_provenance.
NP129257.RA1gWWTZ4ASgzJEzWqhJbS8aE-67c6dZc9GV6rsrHMs8g130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129257.RA1gWWTZ4ASgzJEzWqhJbS8aE-67c6dZc9GV6rsrHMs8g130_provenance.
NP129258.RA7XPS0BfM79JIsVUMe-J_ieoW8p-s_4bXKS5FTbS4wCw130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129258.RA7XPS0BfM79JIsVUMe-J_ieoW8p-s_4bXKS5FTbS4wCw130_provenance.
NP129886.RAwCCEb-fH7lvrCu4k5R2uBcczP5A-nnKNIQujE2pcKhI130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129886.RAwCCEb-fH7lvrCu4k5R2uBcczP5A-nnKNIQujE2pcKhI130_provenance.
NP129910.RA7P8GF4RfUhvQGCr17b8hBYvwa0AljqScdH96K5Kf8tc130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129910.RA7P8GF4RfUhvQGCr17b8hBYvwa0AljqScdH96K5Kf8tc130_provenance.
NP132489.RA5fdcra_wpyZSPz3W8fJKfkwXeNa4fWpeHimMOJ8QsDo130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP132489.RA5fdcra_wpyZSPz3W8fJKfkwXeNa4fWpeHimMOJ8QsDo130_provenance.
NP136260.RA8kT4tsvc824uatof6rU91_-oV1drfGr-JcDRNZ_uGa8130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP136260.RA8kT4tsvc824uatof6rU91_-oV1drfGr-JcDRNZ_uGa8130_provenance.
NP137870.RA1VhfFIgbyQ_tZpJm5PboMWEiAPisfOV-hWBoVisQbAc130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137870.RA1VhfFIgbyQ_tZpJm5PboMWEiAPisfOV-hWBoVisQbAc130_provenance.
NP138356.RAwL9ZbPTvJTibxRQy-l5cItvAlDDxyfwKXA76RTjFq_4130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP138356.RAwL9ZbPTvJTibxRQy-l5cItvAlDDxyfwKXA76RTjFq_4130_provenance.
NP139734.RAxHABjqYqsumi05kunTAGa83cUyhCCAV_tjVf8KwANoA130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139734.RAxHABjqYqsumi05kunTAGa83cUyhCCAV_tjVf8KwANoA130_provenance.
NP139903.RA7q6KnluWcAjsw7wYq1ldEBwbscMITiXpiNbYyBkfk5M130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP139903.RA7q6KnluWcAjsw7wYq1ldEBwbscMITiXpiNbYyBkfk5M130_provenance.
NP143035.RA9JFpCDM88zfLz8GeGRmTQOKyhknopgpKAu9qsUSroyc130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143035.RA9JFpCDM88zfLz8GeGRmTQOKyhknopgpKAu9qsUSroyc130_provenance.
NP143756.RAyuuFn5iYsH24VgBirk9R9Btz13-fq7i2UOFYsMf6LEY130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP143756.RAyuuFn5iYsH24VgBirk9R9Btz13-fq7i2UOFYsMf6LEY130_provenance.
NP145089.RA_Snscp1Mu3j8W-5O-7lL9FPmF8nQGhMSnxKBD13HzMM130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145089.RA_Snscp1Mu3j8W-5O-7lL9FPmF8nQGhMSnxKBD13HzMM130_provenance.
NP145139.RA51hAJHSnCjDolIyS7QO4qlP-tI5hSdvvEZh6ywWwjTU130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145139.RA51hAJHSnCjDolIyS7QO4qlP-tI5hSdvvEZh6ywWwjTU130_provenance.
NP145140.RA6LQkHk-csFW1HvmkKLMKADs2A12_G5uDFZP_p_f_Vt0130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP145140.RA6LQkHk-csFW1HvmkKLMKADs2A12_G5uDFZP_p_f_Vt0130_provenance.
NP110128.RA9I8KxYV7zjmpQrf8FeQOnBKdbIdwN8MaaJ-M6b-HPTw130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP110128.RA9I8KxYV7zjmpQrf8FeQOnBKdbIdwN8MaaJ-M6b-HPTw130_provenance.
NP141949.RA_d1EcH8B10JhZH12ZLE3CV7wxvWH_anXQyNf2QuYg6M130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP141949.RA_d1EcH8B10JhZH12ZLE3CV7wxvWH_anXQyNf2QuYg6M130_provenance.
NP142096.RA5-k7OcWgYfqjO1UXILgz4R3FOmaAQLcOr05Xy08UEmM130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP142096.RA5-k7OcWgYfqjO1UXILgz4R3FOmaAQLcOr05Xy08UEmM130_provenance.
NP140962.RA5F3E5iwR1c1v4jfQwQHP8LtQtvrGmDW4w0koLQi7VaQ130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP140962.RA5F3E5iwR1c1v4jfQwQHP8LtQtvrGmDW4w0koLQi7VaQ130_provenance.
NP149666.RAzkG9CtvcGDQZXBnmGKGmDZfyHp10pEuDh-eRvEQB_Ss130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149666.RAzkG9CtvcGDQZXBnmGKGmDZfyHp10pEuDh-eRvEQB_Ss130_provenance.
NP149881.RAztqmA2L62ocBtVKjdd3ee9Bqo7KNzbfdaEcq2-D6yFs130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP149881.RAztqmA2L62ocBtVKjdd3ee9Bqo7KNzbfdaEcq2-D6yFs130_provenance.
NP150430.RA7ZGG3YXDEbuvU3P5hfP6-lljoilrW3QaUF7jl2Z7DSw130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP150430.RA7ZGG3YXDEbuvU3P5hfP6-lljoilrW3QaUF7jl2Z7DSw130_provenance.
NP150431.RA8zFKE-zgtVXaXn6_TauoKMTsG6iif2WI_GWgzT2Bt1g130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP150431.RA8zFKE-zgtVXaXn6_TauoKMTsG6iif2WI_GWgzT2Bt1g130_provenance.
NP187819.RAAbWoaAi2C2DRTYb2MxuwuvLTtkcP9U4hWVNGfKMDYtY130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187819.RAAbWoaAi2C2DRTYb2MxuwuvLTtkcP9U4hWVNGfKMDYtY130_provenance.
NP187822.RAAr2D_x5ko0GLNZrG75vn3QbeZlzspogBQ91O1lP3-6U130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187822.RAAr2D_x5ko0GLNZrG75vn3QbeZlzspogBQ91O1lP3-6U130_provenance.
NP187838.RADnlIWT-lZIoQlnO7MwhzyE9JlS8sJGY39pHvWxWKy68130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187838.RADnlIWT-lZIoQlnO7MwhzyE9JlS8sJGY39pHvWxWKy68130_provenance.
NP187858.RAAVWo9QTF9xi-ei-PmKRhh6NJxj0TZGYuxzdtncHbkMA130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187858.RAAVWo9QTF9xi-ei-PmKRhh6NJxj0TZGYuxzdtncHbkMA130_provenance.
NP187872.RAAMbAtsPUhxxmv3qd6qUGr9WPe77dnSEgz_OTpAxVkQE130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187872.RAAMbAtsPUhxxmv3qd6qUGr9WPe77dnSEgz_OTpAxVkQE130_provenance.
NP187895.RAB8jhvM5Zl8zE9b2MWYs-rxR27WR3in_auYgmCE5DYaw130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187895.RAB8jhvM5Zl8zE9b2MWYs-rxR27WR3in_auYgmCE5DYaw130_provenance.
NP187899.RABisdSOZxE1LSwCq2P7swx9kPmHcnihdg5KNH2vJyvhw130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187899.RABisdSOZxE1LSwCq2P7swx9kPmHcnihdg5KNH2vJyvhw130_provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP187817.RAx3FVHPVGLBhkrHKFy9uykUY4aKvdEkOJRswxTY1_02U130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187817.RAx3FVHPVGLBhkrHKFy9uykUY4aKvdEkOJRswxTY1_02U130_provenance.
NP187820.RA6pTFyGytDGrUilQ6D2tK-Z-k6imjqwXllWg37mhQxuw130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187820.RA6pTFyGytDGrUilQ6D2tK-Z-k6imjqwXllWg37mhQxuw130_provenance.
NP187832.RAwUwdIm537RefY3GX8E03gJ06C7NbTcU2pTG4MYp5PFU130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187832.RAwUwdIm537RefY3GX8E03gJ06C7NbTcU2pTG4MYp5PFU130_provenance.
NP187833.RA2Ax9T17zKa8AWaKHmzRNuKQbcYzacVW7B8jq9fRrmtQ130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187833.RA2Ax9T17zKa8AWaKHmzRNuKQbcYzacVW7B8jq9fRrmtQ130_provenance.
NP187835.RA018uGemnS_i0EKbWaMfL4dUJ7xJ8I_AnB0R072NWfLs130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187835.RA018uGemnS_i0EKbWaMfL4dUJ7xJ8I_AnB0R072NWfLs130_provenance.
NP187844.RA_jOcXhEKdwShM4uDQ_PjoN6jAOGZrjCzDUFwFA-uvzE130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187844.RA_jOcXhEKdwShM4uDQ_PjoN6jAOGZrjCzDUFwFA-uvzE130_provenance.
NP187853.RA0435uCt4JlhEOS1wouxZHvxXkDGKbt-VYvEJjB55t1A130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187853.RA0435uCt4JlhEOS1wouxZHvxXkDGKbt-VYvEJjB55t1A130_provenance.
NP187857.RA8few7uzdE5QLd7jfK5_b_y27E4cHck128a4G6IpJNr0130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187857.RA8few7uzdE5QLd7jfK5_b_y27E4cHck128a4G6IpJNr0130_provenance.
NP187859.RA4OYPIMCFvo5rcJnu618KvQ2OZowyhmTyCvSCylBVMTs130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187859.RA4OYPIMCFvo5rcJnu618KvQ2OZowyhmTyCvSCylBVMTs130_provenance.
NP187869.RAzSFMXR6vHdQH5eacR6TEVQ1ooAsEAJD55amTklLCnFQ130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187869.RAzSFMXR6vHdQH5eacR6TEVQ1ooAsEAJD55amTklLCnFQ130_provenance.
NP187870.RAxEAdxiIxIMAtufx0kWpb8_s7yjiwLh7m51ZMj9bhboU130_assertion description "[Genetic variation in AKT1 may mediate both short-term as well as longer-term effects on psychosis expression associated with use of cannabis, possibly through a mechanism of cannabinoid-regulated AKT1/GSK-3 signaling downstream of the dopamine D(2) recept]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187870.RAxEAdxiIxIMAtufx0kWpb8_s7yjiwLh7m51ZMj9bhboU130_provenance.